Aureate Tradde’s IPO highlights how India’s SME exchanges are enabling smaller companies to access growth capital and build public-market visibility earlier than ever before.
Investors are increasingly focusing on Bharat-focused startups solving distribution, manufacturing and regional-market challenges, signaling a shift away from purely metro-centric consumer internet models.
Aurm’s funding round highlights a growing investor shift toward startups combining technology with physical infrastructure, reflecting renewed interest in hard-asset business models.
Sychedelic’s funding highlights growing investor curiosity around neurotechnology, as AI-powered brain-tech wearables begin emerging as a new category within India’s startup ecosystem.
HealthFab’s appearance in seed-stage funding trackers reflects growing investor interest in women-focused healthcare, menstrual wellness and preventive health infrastructure across India.
Samsung’s 2026 startup incubation program is offering grants of up to $50,000 without taking equity, highlighting growing interest in non-dilutive funding for deep-tech founders.
As AI startups multiply across industries, investors and enterprise customers are increasingly prioritizing validation, recognition and measurable outcomes over AI branding alone.
June 2026 is witnessing a fresh wave of SME IPO activity led by Merritronix, Aureate Tradde and Liotech Industries, highlighting strong fundraising momentum among emerging Indian businesses.
India's primary market has been unusually quiet in 2026, but Hexagon Nutrition's ₹138.87 crore IPO could mark the beginning of a broader revival. With over three decades of operating history, exports to more than 75 countries, and a profitable growth trajectory, the Mumbai-based nutrition company enters the public markets as June's only confirmed mainboard IPO. The offering provides investors exposure to India's expanding nutrition and healthcare ecosystem while highlighting the growing importance of preventive health and clinical nutrition globally.
Global stock markets are reaching new highs, but beneath the headline returns lies a striking reality: just 1% of listed companies are responsible for nearly 95% of equity wealth creation in 2026. As mega-cap technology firms dominate global indices, investors face growing concentration risk hidden behind the illusion of diversification.